… Olsen and Gøtzsche1 (OG) describing their overview of the mammographic screening trials.
… indicate any survival benefit of mass screening for breast cancer,” and they maintained that …

… Follow-up after 11 years: update of mortality results in the Stockholm mammographic
screening trial. … and mortality from breast cancer: the Malmo mammographic screening trial. …

… Gøtzsche and Olsen judge the effect of mammography screening on the basis of the Canadian
trial … The Malmö trial is valid but Gøtzsche and Olsen do not use more recently published …

… some of the trials. Considerably … Gøtzsche and Olsen do, that a difference of less than 5
weeks in average age renders the randomisation so imperfect as to nullify the results of the study …

… Olsen and Gøtzsche conclude that screening mammography … Olsen and Gøtzsche’s decision
to deem certain clinical trials … in mean age between screening and control groups.Meta-…

… after mass screening with mammography. Randomised trial from the Breast Cancer Screening
… on the raw data from all the screening trials, using total mortality as the primary outcome. …

… trials of mammography screening and revised their guidelines, recommending that women
between the ages of 50 and 74 have a screening mammography … by Olsen and Gøtzsche. J …

… The expectations from mammography screening have been high. Based on … trials, the New
York HIP trial and the Two-County trial, the UK Forrest report assumed in 1986 that screening …

… Over the past three decades, a considerable body of randomized trial evidence has
accumulated demonstrating that mammographic screening for breast cancer can substantially …

… I believe Olsen and Gøtzsche’s previous criticisms about randomisation have been … trial of
breast cancer5 allowed for cluster randomisation, which RevMan cannot do. Two of that study’…